Form 4: Fennec Pharmaceuticals Insider Sells Shares
Insider Transaction (Form 4)
Rosty Raykov, Former Director of Fennec Pharmaceuticals Inc., sold 10,000 shares of common stock on August 31, 2026 for $12.11 per share.
Summary
- Grant/award: acquired 2,778 Common shares on August 31, 2026; holds 134,411 after (Direct).
- Open-market sale: disposed of 10,000 Common shares at $12.11 ($121,100) on September 1, 2026; holds 124,411 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $121,100 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Rosty Raykov — Other (Former Director)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Grant/award | Common shares | 2,778 | — | — | 134,411 |
| 2026-09-01 | Open-market sale | Common shares | 10,000 | $12 | $121.1K | 124,411 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Grant/award (2,778 shares) |
| 2026-09-01 | Open-market sale (10,000 shares) |
Keywords
insider transaction, Form 4, FENC, FENNEC PHARMACEUTICALS INC., bearish, Rosty Raykov
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.